Indivior (LON:INDV) Shares Down 20.6% – Here’s Why

Indivior PLC (LON:INDV)’s stock price was down 20.6% during trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 689.44 ($8.71). Approximately 2,685,740 shares traded hands during mid-day trading, an increase of 267% from the average daily volume of 731,626 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 1,800 ($22.74) price objective on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Performance

The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The stock has a market cap of £1.08 billion, a price-to-earnings ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The stock’s 50-day moving average is GBX 920.11 and its 200 day moving average is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.